D
Defence Therapeutics Inc
CNSX:DTC
Defence Therapeutics Inc
CNSX:DTC
Price:
0.52
CAD
-1.89%
Market Closed
Market Cap:
CA$29.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Defence Therapeutics Inc
CNSX:DTC
|
CA |
|
A
|
Amplifon SpA
LSE:0N61
|
IT |
Income Statement
Earnings Waterfall
Defence Therapeutics Inc
Defence Therapeutics Inc
Income Statement
Defence Therapeutics Inc
Defence Therapeutics Inc
Currency: CAD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(1)
|
(2)
|
(3)
|
(4)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(5)
|
(12)
|
(12)
|
(13)
|
(11)
|
(4)
|
(3)
|
(3)
|
(3)
|
(4)
|
|
| Selling, General & Administrative |
(0)
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(4)
|
(3)
|
(2)
|
(3)
|
(3)
|
(9)
|
(8)
|
(9)
|
(8)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
|
| Research & Development |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(5)
|
(5)
|
(4)
|
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Operating Income |
(1)
N/A
|
(2)
-44%
|
(3)
-74%
|
(4)
-52%
|
(6)
-35%
|
(7)
-17%
|
(7)
-7%
|
(7)
-2%
|
(7)
+0%
|
(7)
+6%
|
(5)
+25%
|
(12)
-121%
|
(12)
+0%
|
(13)
-10%
|
(11)
+13%
|
(4)
+68%
|
(3)
+5%
|
(3)
+3%
|
(3)
-2%
|
(4)
-23%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(1)
N/A
|
(2)
-44%
|
(3)
-74%
|
(4)
-52%
|
(6)
-35%
|
(7)
-17%
|
(7)
-7%
|
(8)
-2%
|
(8)
-1%
|
(7)
+5%
|
(6)
+23%
|
(12)
-115%
|
(12)
+0%
|
(13)
-11%
|
(12)
+12%
|
(4)
+65%
|
(4)
+9%
|
(4)
+5%
|
(4)
-3%
|
(4)
-20%
|
|
| Net Income | |||||||||||||||||||||
| Income from Continuing Operations |
(1)
|
(2)
|
(3)
|
(4)
|
(6)
|
(7)
|
(7)
|
(8)
|
(8)
|
(7)
|
(6)
|
(12)
|
(12)
|
(13)
|
(12)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
|
| Net Income (Common) |
(1)
N/A
|
(1)
+40%
|
(3)
-314%
|
(4)
-37%
|
(6)
-50%
|
(7)
-17%
|
(7)
-7%
|
(8)
-2%
|
(8)
-1%
|
(7)
+5%
|
(6)
+23%
|
(12)
-115%
|
(12)
+0%
|
(13)
-11%
|
(12)
+12%
|
(4)
+65%
|
(4)
+9%
|
(4)
+5%
|
(4)
-3%
|
(4)
-20%
|
|
| EPS (Diluted) |
-0.03
N/A
|
-0.01
+67%
|
-0.11
-1 000%
|
-0.11
N/A
|
-0.18
-64%
|
-0.21
-17%
|
-0.2
+5%
|
-0.21
-5%
|
-0.21
N/A
|
-0.19
+10%
|
-0.14
+26%
|
-0.27
-93%
|
-0.27
N/A
|
-0.3
-11%
|
-0.26
+13%
|
-0.09
+65%
|
-0.08
+11%
|
-0.07
+12%
|
-0.07
N/A
|
-0.08
-14%
|
|
Switch to:
Switch to:
See Also
Discover More
